Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Petroni

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Gynecologic Oncology|April 6, 2020
A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinomaL R Duska, G R Petroni, N Varhegyi, et al.
Journal for Immunotherapy of Cancer|August 16, 2014
A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodesPatrick M Dillon, Walter C Olson, Andrea Czarkowski, et al.
Annals of Surgery|April 9, 2011
Intraoperative imaging guidance for sentinel node biopsy in melanoma using a mobile gamma cameraLynn T Dengel, Mitali J More, Patricia G Judy, et al.
Cancer Immunology, Immunotherapy : CII|May 13, 2005
Low-dose IL-2 induces cytokine cascade, eosinophilia, and a transient Th2 shift in melanoma patientsWilliam Chad Cragun, Galina V Yamshchikov, Eric A Bissonette, et al.
Blood Advances|October 26, 2021
Dose-finding study of ibrutinib and venetoclax in relapsed or refractory mantle cell lymphomaCraig A Portell, Nolan A Wages, Brad S Kahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114J E Tepper, M J O'Connell, G R Petroni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancerK K Jain, E S Casper, N L Geller, et al.
Journal of Cancer Survivorship : Research and Practice|May 29, 2013
Factors related to decision making and substance use in adolescent survivors of childhood cancer: a presenting clinical profileP J Hollen, V L Tyc, S V Shannon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Phase I trial of induction histone deacetylase and proteasome inhibition followed by surgery in non-small-cell lung cancerDavid R Jones, Christopher A Moskaluk, Heidi H Gillenwater, et al.
Clinical Trials (London, England)|July 3, 2010
Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trialsAnneke T Schroen, Gina R Petroni, Hongkun Wang, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Gynecologic Oncology|April 6, 2020
A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinomaL R Duska, G R Petroni, N Varhegyi, et al.
Journal for Immunotherapy of Cancer|August 16, 2014
A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodesPatrick M Dillon, Walter C Olson, Andrea Czarkowski, et al.
Annals of Surgery|April 9, 2011
Intraoperative imaging guidance for sentinel node biopsy in melanoma using a mobile gamma cameraLynn T Dengel, Mitali J More, Patricia G Judy, et al.
Cancer Immunology, Immunotherapy : CII|May 13, 2005
Low-dose IL-2 induces cytokine cascade, eosinophilia, and a transient Th2 shift in melanoma patientsWilliam Chad Cragun, Galina V Yamshchikov, Eric A Bissonette, et al.
Blood Advances|October 26, 2021
Dose-finding study of ibrutinib and venetoclax in relapsed or refractory mantle cell lymphomaCraig A Portell, Nolan A Wages, Brad S Kahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114J E Tepper, M J O'Connell, G R Petroni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancerK K Jain, E S Casper, N L Geller, et al.
Journal of Cancer Survivorship : Research and Practice|May 29, 2013
Factors related to decision making and substance use in adolescent survivors of childhood cancer: a presenting clinical profileP J Hollen, V L Tyc, S V Shannon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Phase I trial of induction histone deacetylase and proteasome inhibition followed by surgery in non-small-cell lung cancerDavid R Jones, Christopher A Moskaluk, Heidi H Gillenwater, et al.
Clinical Trials (London, England)|July 3, 2010
Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trialsAnneke T Schroen, Gina R Petroni, Hongkun Wang, et al.
Pageof 13